EUVIMEDEUVIMED entdecken
Crossref

Hypophysitis and Secondary Adrenal Insufficiency From Immune Checkpoint Inhibitors: Diagnostic Challenges and Link With Survival

Jake Johnson, Whitney Goldner, Duaa Abdallah, Fang Qiu, Apar Kishor Ganti, Anupam Kotwal

Journal of the National Comprehensive Cancer Network · 2023

DOI: 10.6004/jnccn.2022.7098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2023. Verfasst von Jake Johnson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska. Hauptthemen laut MEDLINE: Antineoplastic Agents, Immunological, Melanoma, Adrenal Insufficiency, Hypophysitis. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypophysitis is a serious adverse event stemming from immune checkpoint inhibitor (ICI) therapy for malignancy. This study aimed to characterize ICI-induced hypophysitis, identify diagnostic challenges, and evaluate an association with survival in a large cancer cohort.

Methods

We performed a retrospective cohort study of adult patients with cancer who received ICIs between December 1, 2012, and December 31, 2019. We identified 839 patients who received CTLA-4, PD-1, or PD-L1 inhibitors or a combination thereof who were followed for a median of 19.4 months. Hypophysitis was defined as MRI evidence of pituitary gland and/or stalk enlargement or biochemical evidence of hypopituitarism if not explained by another etiology.

Results

A total of 16 (1.9%) patients developed hypophysitis a median of 7 months after ICI initiation, with most patients having melanoma (9/16; 56.2%) or renal cell carcinoma (4/16; 25%). Two patients also had exogenous glucocorticoid exposure but exhibited secondary hypothyroidism and secondary adrenal insufficiency (AI). Median age at the start of ICI was 61.3 years and 57% were men. Patients who developed hypophysitis were younger compared with those who did not develop hypophysitis (median age, 57 vs 65 years; P =.011). Hypophysitis occurred most frequently after combination therapy (13.7%) compared with CTLA-4 monotherapy (1.9%), PD-1 monotherapy (1.2%), and PD-L1 monotherapy (0.8%) ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Agents, ImmunologicalMelanomaAdrenal InsufficiencyHypophysitisKidney NeoplasmsHypothyroidismMaleAdultHumansMiddle AgedFemaleImmune Checkpoint InhibitorsCTLA-4 AntigenProgrammed Cell Death 1 ReceptorRetrospective StudiesGlucocorticoids

Stichwörter der Autor:innen

Survivaladrenalcancerimmunotherapypituitary

Substanzen

Immune Checkpoint InhibitorsCTLA-4 AntigenAntineoplastic Agents, ImmunologicalProgrammed Cell Death 1 ReceptorGlucocorticoids

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
  • Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
  • Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska.
  • Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska.
  • Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
  • VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska.

Zitieren

APA

Johnson, J., Goldner, W., Abdallah, D., Qiu, F., Ganti, A. K., & Kotwal, A. (2023). Hypophysitis and Secondary Adrenal Insufficiency From Immune Checkpoint Inhibitors: Diagnostic Challenges and Link With Survival. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2022.7098

Vancouver

Johnson J, Goldner W, Abdallah D, Qiu F, Ganti AK, Kotwal A. Hypophysitis and Secondary Adrenal Insufficiency From Immune Checkpoint Inhibitors: Diagnostic Challenges and Link With Survival. Journal of the National Comprehensive Cancer Network. 2023. doi:10.6004/jnccn.2022.7098

BibTeX
@article{Johnson2023,
  author = {Johnson, Jake and Goldner, Whitney and Abdallah, Duaa and Qiu, Fang and Ganti, Apar Kishor and Kotwal, Anupam},
  title = {Hypophysitis and Secondary Adrenal Insufficiency From Immune Checkpoint Inhibitors: Diagnostic Challenges and Link With Survival},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2023},
  doi = {10.6004/jnccn.2022.7098}
}
Kostenlos starten →